Miguel Carracedo

BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction: Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells.

Correction: Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells.

Journal: Angiogenesis

Published: June 26, 2024

Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells.

Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells.

Journal: Angiogenesis

Published: December 01, 2023

Head-to-head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells.

Head-to-head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells.

Journal: Journal of extracellular vesicles

Published: November 15, 2023

3D vascularised proximal tubules-on-a-multiplexed chip model for enhanced cell phenotypes.

3D vascularised proximal tubules-on-a-multiplexed chip model for enhanced cell phenotypes.

Journal: Lab on a chip

Published: June 21, 2023

APOL1 promotes endothelial cell activation beyond the glomerulus.

APOL1 promotes endothelial cell activation beyond the glomerulus.

Journal: iScience

Published: March 30, 2023

The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.

The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.

Journal: British journal of pharmacology

Published: December 16, 2020

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection.

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection.

Journal: The Journal of clinical investigation

Published: August 03, 2020

TLR7 Expression Is Associated with M2 Macrophage Subset in Calcific Aortic Valve Stenosis.

TLR7 Expression Is Associated with M2 Macrophage Subset in Calcific Aortic Valve Stenosis.

Journal: Cells

Published: June 15, 2020

Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis.

Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis.

Journal: Circulation

Published: June 09, 2020

FADS1 (Fatty Acid Desaturase 1) Genotype Associates With Aortic Valve FADS mRNA Expression, Fatty Acid Content and Calcification.

FADS1 (Fatty Acid Desaturase 1) Genotype Associates With Aortic Valve FADS mRNA Expression, Fatty Acid Content and Calcification.

Journal: Circulation. Genomic and precision medicine

Published: May 14, 2020

Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification.

Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification.

Journal: Cells

Published: January 22, 2020

The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification.

The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification.

Journal: Seminars in immunopathology

Published: August 26, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026